Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
NAII 
Natural Alternatives International (NAII)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/21/2025: NAII (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -49.4% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/21/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 19.90M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.63 | 52 Weeks Range 2.57 - 6.88 | Updated Date 06/29/2025 |
52 Weeks Range 2.57 - 6.88 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.39 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -6.56% | Operating Margin (TTM) 7.87% |
Management Effectiveness
Return on Assets (TTM) -3.75% | Return on Equity (TTM) -10.25% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 67902418 | Price to Sales(TTM) 0.16 |
Enterprise Value 67902418 | Price to Sales(TTM) 0.16 | ||
Enterprise Value to Revenue 0.54 | Enterprise Value to EBITDA 74.97 | Shares Outstanding 6178900 | Shares Floating 4878116 |
Shares Outstanding 6178900 | Shares Floating 4878116 | ||
Percent Insiders 21.59 | Percent Institutions 33.51 |
Upturn AI SWOT
Natural Alternatives International
Company Overview
History and Background
Natural Alternatives International, Inc. (NAII) was founded in 1980. It began by manufacturing private label nutritional supplements. Over time, NAII has expanded its services to include scientific research, product development, and comprehensive manufacturing solutions for nutritional supplement companies.
Core Business Areas
- Contract Manufacturing: NAII provides contract manufacturing services for branded nutritional supplement companies. This includes formulation, blending, tableting, encapsulation, and packaging.
- Private Label Manufacturing: NAII also offers private label manufacturing services, where it produces and packages products under the client's brand.
- Product Development and Scientific Support: The company supports its clients with product development, scientific research, and regulatory compliance.
Leadership and Structure
Mark A. LeDoux serves as the Chairman and CEO. The organizational structure includes departments for operations, research and development, sales and marketing, and finance.
Top Products and Market Share
Key Offerings
- Branded Ingredients (e.g., CarnoSyn beta-alanine): NAII develops and markets branded ingredients like CarnoSyn beta-alanine, which is used to enhance athletic performance. While exact market share data is not publicly available, CarnoSyn is a leading beta-alanine brand. Competitors include other beta-alanine manufacturers and providers of alternative performance-enhancing supplements.
- Custom Formulations: NAII formulates and manufactures custom blends for various clients in the sports nutrition, health, and wellness industries. Market share varies depending on client success. Competitors are other contract manufacturing companies.
- Finished Products: NAII manufactures finished dietary supplement products for distribution by their customers. Competitors are other contract manufacturing companies.
Market Dynamics
Industry Overview
The nutritional supplement industry is experiencing continued growth, driven by increasing consumer awareness of health and wellness, aging populations, and the rise of personalized nutrition. The industry is competitive and subject to regulatory scrutiny.
Positioning
NAII positions itself as a science-backed, vertically integrated provider of nutritional supplement solutions. Its competitive advantages include its patented ingredients (like CarnoSyn) and its comprehensive service offerings, including research, development, and manufacturing.
Total Addressable Market (TAM)
The global dietary supplements market is projected to reach hundreds of billions of dollars. NAII's position is to capture a segment of this market through its branded ingredients and contract manufacturing services, targeting specific niches like sports nutrition and healthy aging.
Upturn SWOT Analysis
Strengths
- Proprietary ingredients (e.g., CarnoSyn)
- Vertically integrated operations
- Strong scientific and R&D capabilities
- Established relationships with branded supplement companies
- Experienced management team
Weaknesses
- Customer concentration
- Limited brand recognition outside of CarnoSyn
- Dependence on raw material supply chains
- Small Company size compared to Key Competitors
Opportunities
- Expanding into new markets and geographies
- Developing new and innovative ingredients
- Capitalizing on the growing demand for personalized nutrition
- Acquiring complementary businesses
- Increased focus on sustainability
Threats
- Increased competition from larger players
- Changes in regulations and consumer preferences
- Economic downturns impacting consumer spending
- Raw material price fluctuations
- Negative publicity related to the supplement industry
Competitors and Market Share
Key Competitors
- Nutraceutical International Corporation (NUTR)
- Archer-Daniels-Midland Company (ADM)
- Lonza Group (LZAGY)
Competitive Landscape
NAII faces stiff competition from larger, more diversified players. Its strength lies in its proprietary ingredients and scientific expertise. However, it must continue to innovate and expand its product offerings to maintain its competitive edge.
Growth Trajectory and Initiatives
Historical Growth: Data unavailable without a live data feed. Refer to NAII's investor relations page for accurate up-to-date data.
Future Projections: Data unavailable without a live data feed. Refer to analyst reports for projections.
Recent Initiatives: NAII has been focused on expanding its CarnoSyn applications and production capacity, as well as streamlining its manufacturing operations.
Summary
Natural Alternatives International is a vertically integrated company with strengths in proprietary ingredients and scientific capabilities. The company faces competition from larger, more diversified entities and must innovate to maintain its competitive edge. Customer concentration is a weakness. However, the nutritional supplement market is growing, providing opportunities for further expansion.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Company SEC Filings
- Industry Reports
- Analyst Reports
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It should not be considered financial advice. Market share data are approximate and may vary based on source and methodology.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Natural Alternatives International
Exchange NASDAQ | Headquaters Carlsbad, CA, United States | ||
IPO Launch date 1987-03-13 | Chairman of the Board & CEO Mr. Mark A. LeDoux J.D. | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 296 | Website https://www.nai-online.com |
Full time employees 296 | Website https://www.nai-online.com | ||
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, the company sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.